Relief Therapeutics

Supporting patients through innovation and technology

Drivers

All our activities converge to provide benefit to the patients in need. Our utmost priority is hence to ensure optimum benefit / risk ratio in all our development endeavours.

We aim at rapidly providing patients with alternative treatment options that are safe and efficacious. Our most advanced programs address Diabetic Neuropathy and the pulmonary orphan indication Sarcoidosis, both of which lack transformational medication.